Novel sublingual tablets of Atorvastatin calcium (cas 134523-03-8)/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization
-
Add time:08/01/2019 Source:sciencedirect.com
BackgroundIschemic heart disorders and accumulation of lipids in blood vessels could contribute to angina pectoris. Therefore, the aim of this study was to formulate sublingual tablets containing a novel combination of Atorvastatin calcium (ATOR) and Trimetazidine HCl (TMZ) for efficient treatment of coronary heart disorders.
We also recommend Trading Suppliers and Manufacturers of Atorvastatin calcium (cas 134523-03-8). Pls Click Website Link as below: cas 134523-03-8 suppliers
Prev:The studies of PLGA nanoparticles loading Atorvastatin calcium (cas 134523-03-8) for oral administration in vitro and in vivo
Next:Chemically modified carbon paste ion-selective electrodes for determination of Atorvastatin calcium (cas 134523-03-8) in pharmaceutical preparations) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Physicochemical characteristics of the complexes of simvastatin and Atorvastatin calcium (cas 134523-03-8) with hydroxypropyl-β-cyclodextrin produced by mechanochemical activation08/06/2019
- Development and validation of RP-HPLC method for determination of Atorvastatin calcium (cas 134523-03-8) and Nicotinic acid in combined tablet dosage form08/05/2019
- Atorvastatin calcium (cas 134523-03-8) in combination with methylprednisolone for the treatment of multiple sclerosis relapse08/04/2019
- UHPLC-MS/MS method for determination of Atorvastatin calcium (cas 134523-03-8) in human plasma: Application to a pharmacokinetic study based on healthy volunteers with specific genotype08/03/2019
- Chemically modified carbon paste ion-selective electrodes for determination of Atorvastatin calcium (cas 134523-03-8) in pharmaceutical preparations08/02/2019
- The studies of PLGA nanoparticles loading Atorvastatin calcium (cas 134523-03-8) for oral administration in vitro and in vivo07/31/2019
- Preparation, characterization, and in vitro/vivo evaluation of polymer-assisting formulation of Atorvastatin calcium (cas 134523-03-8) based on solid dispersion technique07/30/2019
-
Health and Chemical more >
-
Related Products
- Atorvastatin Acyl-b-D-glucuronide
- Atorvastatin calcium
- Atorvastatin lactone
- Atorvastatin sodium salt
- Atorvastatin tert-Butyl Ester
- Calcium valproate
- Calcium (1)-bis(2-hydroxy-4-methylvalerate)
- Calcium (2S)-2-[(4-chlorobenzoyl)amino]-3-(1H-indol-3-yl)propanoate
- Calcium (S)-3-methyl-2-oxovalerate
- Calcium 2,4-dichlorophenolate